NinePointTwo Capital »

Jazz Pharmaceuticals shares owned by NinePointTwo Capital

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by NinePointTwo Capital from 13F filings

Historical chart of NinePointTwo Capital investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by NinePointTwo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by NinePointTwo Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $245k 2.0k 122.99
2023-09-30 $257k 2.0k 129.02

More positions owned by NinePointTwo Capital

Schwab Strategic Tr Us Tips Etf (SCHP)
Vaneck Etf Trust Jp Mrgan Em Loc (EMLC)
Ishares Tr Tips Bd Etf (TIP)
Dbx Etf Tr Xtrack Usd High (HYLB)
Vanguard Whitehall Fds High Div Yld (VYM)
Invesco Actvely Mngd Etc Optimum Yield (PDBC)
Ishares Tr Select Divid Etf (DVY)
Apollo Global Mgmt (APO)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Apple (AAPL)
Hca Holdings (HCA)
Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Meta Platforms Cl A (META)
Nxp Semiconductors N V (NXPI)

View all positions for NinePointTwo Capital

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
LSV Asset Management
Pacer Advisors
State Street Corporation
Capital World Investors
Dimensional Fund Advisors
EcoR1 Capital
Jpmorgan Chase & Co
Ameriprise Financial
Camber Capital Management
Franklin Resources
Geode Capital Management
Citadel Advisors
Polaris Capital Management

View all funds holding Jazz Pharmaceuticals